UBS Asset Management Form 8.3 - Takeda Pharmaceutical (5323M)

TIDMSHP TIDM0RN3

RNS Number : 5323M

UBS Asset Management

08 January 2019

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                     UBS Asset Management 
                                                  * 
 (b) Owner or controller of interests 
  and short positions disclosed, if 
  different from 1(a): 
  The naming of nominee or vehicle 
  companies is insufficient. For a 
  trust, the trustee(s), settlor and 
  beneficiaries must be named. 
                                                ---------------------- 
 (c) Name of offeror/offeree in relation         Takeda Pharmaceutical 
  to whose relevant securities this               Co Ltd 
  form relates: 
  Use a separate form for each offeror/offeree 
                                                ---------------------- 
 (d) If an exempt fund manager connected 
  with an offeror/offeree, state this              n/a 
  and specify identity of offeror/offeree: 
                                                ---------------------- 
 (e) Date position held/dealing undertaken:      07 Jan 2019 
  For an opening position disclosure, 
  state the latest practicable date 
  prior to the disclosure 
                                                ---------------------- 
 (f) In addition to the company in               NO 
  1(c) above, is the discloser making 
  disclosures in respect of any other 
  party to the offer? 
  If it is a cash offer or possible 
  cash offer, state "N/A" 
                                                ---------------------- 
 
   2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 
 Class of relevant security:                      Ordinary shares 
                                        Interests             Short positions 
                                 -----------------------  ----------------------- 
                                     Number         %         Number         % 
                                 --------------  -------  --------------  ------- 
 (1) Relevant securities 
  owned and/or controlled:           11,356,399     1.45               0     0.00 
                                 --------------  -------  --------------  ------- 
 (2) Cash-settled derivatives:                0     0.00               0     0.00 
                                 --------------  -------  --------------  ------- 
 (3) Stock-settled derivatives 
  (including options) and 
  agreements to purchase/sell:                0     0.00               0     0.00 
                                 --------------  -------  --------------  ------- 
 
   TOTAL:                            11,356,399     1.45               0     0.00 
                                 --------------  -------  --------------  ------- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

   (b)        Rights to subscribe for new securities (including directors' and other employee options) 
 
 Class of relevant security 
  in relation to which subscription 
  right exists: 
 Details, including nature 
  of the rights concerned and 
  relevant percentages: 
 
 
   3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

   (a)        Purchases and sales 
 
 Class of relevant     Purchase/sale    Number of securities   Price per unit 
      security 
 Ordinary shares      PURCHASE                           500     4,065.000000 
                                                                          JPY 
                     ----------------  ---------------------  --------------- 
 Ordinary shares      PURCHASE                         2,500     3,995.000000 
                                                                          JPY 
                     ----------------  ---------------------  --------------- 
 Ordinary shares      SALE                             4,600     3,995.000000 
                                                                          JPY 
                     ----------------  ---------------------  --------------- 
 Ordinary shares      SALE                             7,000     4,065.000000 
                                                                          JPY 
                     ----------------  ---------------------  --------------- 
  TOTAL PURCHASE                                       3,000 
 ------------------------------------  ---------------------  --------------- 
  TOTAL SALE                                          11,600 
 ------------------------------------  ---------------------  --------------- 
 
   (b)        Cash-settled derivative transactions 
 
 Class of      Product         Nature of dealing       Number of    Price per 
  relevant    description     e.g. opening/closing     reference       unit 
  security     e.g. CFD      a long/short position,    securities 
                              increasing/reducing 
                             a long/short position 
 
 
   (c)        Stock-settled derivative transactions (including options) 
   (i)         Writing, selling, purchasing or varying 
 
    Class         Product        Writing,          Number       Exercise         Type         Expiry    Option 
  of relevant    description    purchasing,     of securities     price      e.g. American,    date      money 
   security       e.g. call       selling,        to which       per unit       European                 paid/ 
                   option       varying etc.       option                         etc.                  received 
                                                   relates                                              per unit 
 
 
   (ii)        Exercise 
 
 Class of relevant   Product description      Exercising/        Number of     Exercise 
      security         e.g. call option     exercised against    securities    price per 
                                                                                 unit 
 
 
   (d)        Other dealings (including subscribing for new securities) 
 
 Class of relevant    Nature of dealing       Details            Price per 
      security        e.g. subscription,                    unit (if applicable) 
                          conversion 
 Ordinary shares     TRANSFER IN                   2,100            3,705.000000 
                                                                             JPY 
                    --------------------  --------------  ---------------------- 
 Ordinary shares     TRANSFER OUT                  2,100            4,545.978095 
                                                                             JPY 
                    --------------------  --------------  ---------------------- 
 
   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any 
  agreement or understanding, formal or informal, relating 
  to relevant securities which may be an inducement to deal 
  or refrain from dealing entered into by the person making 
  the disclosure and any party to the offer or any person 
  acting in concert with a party to the offer: 
  Irrevocable commitments and letters of intent should not 
  be included. If there are no such agreements, arrangements 
  or understandings, state "none" 
 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, 
  formal or informal, between the person making the disclosure 
  and any other person relating to: 
  (i) the voting rights of any relevant securities under 
  any option; or 
  (ii) the voting rights or future acquisition or disposal 
  of any relevant securities to which any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, 
  state "none" 
 
 
   (c)        Attachments 
 
 Is a Supplemental Form 8 (Open Positions) attached?   NO 
 
 
 Date of disclosure:    08/01/2019 
 Contact name:          Mr James Mortimer 
                       ------------------ 
 Telephone number:      [phone] 
                       ------------------ 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [e-mail]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on [phone].

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

* this report is on behalf of:

UBS AG (UBS Asset Management operating in Switzerland)

UBS Asset Management (Americas) Inc.

UBS Asset Management (Australia) Ltd

UBS Asset Management (Hong Kong) Limited

UBS Asset Management (Singapore) Ltd

UBS Asset Management (Taiwan) Ltd

UBS Asset Management (UK) Ltd

UBS La Maison de Gestion

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

RETCKFDBBBKDFDK

(END) Dow Jones Newswires

January 08, 2019 07:29 ET (12:29 GMT)